Navigating the opportunities and challenges in the pharmaceutical landscape of 2024
In 2024, the pharmaceutical industry finds itself confronting high complexity and competition — embracing innovative strategies to navigate these challenges is paramount to ensuring commercial success.
In his recent article featured in PharmaLive, Inizio’s Chief Operating Officer, Ryan Quigley, shares insights into:
- The importance of an integrated approach in complex launches
- Navigating precision in product launches
- The transformative power of artificial intelligence
- The evolution of RWE: embracing technology and data-driven approaches in market access strategies
To learn more about the opportunities and challenges in the current pharmaceutical landscape, contact us.
Jump to a slide with the slide dots.
Start small: Kelly Malloy’s playbook for modernizing MSL training with GenAI.
At Fierce Pharma Week, Kelly Malloy (Senior Vice President of Customer Engagement for AI and Augmented Intelligence), laid out a pragmatic, evidence-b
Read moreIs ChatGPT a friend or foe to pharma marketers?
The rise of AI tools like ChatGPT, Gemini, and Perplexity is transforming how patients and healthcare professionals search for health information.
Read more12 Questions with Remco op den Kelder
Remco op den Kelder shares his leadership path, AI insights & vision for patient-focused pharma strategy in this Q&A with pharmaphorum.
Read more